• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹膜癌病:播散特征。综述

Peritoneal carcinomatosis: feature of dissemination. A review.

作者信息

Deraco M, Santoro N, Carraro O, Inglese M G, Rebuffoni G, Guadagni S, Somers D C, Vaglini M

机构信息

Division of General Surgery B, Istituto Nazionale Tumori, Milan, Italy.

出版信息

Tumori. 1999 Jan-Feb;85(1):1-5. doi: 10.1177/030089169908500101.

DOI:10.1177/030089169908500101
PMID:10228488
Abstract

Peritoneal carcinomatosis is a common event that develops in the natural history of many neoplastic diseases, representing a major problem encountered in cancer, management. Peritoneal seedings are often associated with neoplastic ascites resulting in a source of significant discomfort to the patient. Considered in the past as a terminal condition, peritoneal carcinomatosis was approached during the last two decades as a curable disease. The introduction of cytoreductive surgery or peritonectomy in the treatment of peritoneal neoplastic diseases drastically changed the natural history of peritoneal carcinomatosis. Another technique that showed an important impact on disease control is intraperitoneal hyperthermic perfusion, one of the most fascinating treatments of peritoneal carcinomatosis that results in an impressive increase in overall survival and quality of life in treated patients with low morbidity. This review illustrates the modality of dissemination of peritoneal carcinomatosis in relation to the primary tumor site and grade of malignancy. Peritoneal carcinomatosis is a term used to define an advanced stage of many abdominal neoplastic diseases that differ in biologic aggressiveness and prognosis. The different presentation of peritoneal carcinomatosis in relation to a different primary tumor and different grade of malignancy strongly influences the potentially therapeutic radical approaches using new and advanced modalities like cytoreductive surgery and intraperitoneal hyperthermic perfusion.

摘要

腹膜癌病是许多肿瘤性疾病自然病程中常见的情况,是癌症治疗中遇到的一个主要问题。腹膜种植常伴有肿瘤性腹水,给患者带来极大不适。腹膜癌病过去被认为是终末期疾病,但在过去二十年中被视为可治愈的疾病。细胞减灭术或腹膜切除术应用于腹膜肿瘤性疾病的治疗,极大地改变了腹膜癌病的自然病程。另一种对疾病控制有重要影响的技术是腹腔热灌注化疗,这是治疗腹膜癌病最引人注目的方法之一,能使接受治疗患者的总生存率显著提高,生活质量改善,且发病率较低。本文综述了腹膜癌病相对于原发肿瘤部位和恶性程度的播散方式。腹膜癌病是一个用于定义许多腹部肿瘤性疾病晚期阶段的术语,这些疾病在生物学侵袭性和预后方面存在差异。腹膜癌病因不同的原发肿瘤和不同的恶性程度而表现各异,这强烈影响了使用细胞减灭术和腹腔热灌注化疗等新的先进方法进行潜在治疗的根治性手段。

相似文献

1
Peritoneal carcinomatosis: feature of dissemination. A review.腹膜癌病:播散特征。综述
Tumori. 1999 Jan-Feb;85(1):1-5. doi: 10.1177/030089169908500101.
2
[Cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion for peritoneal carcinomatosis caused by recurrent inflammatory myofibroblastic sarcoma: a case report and review of the literature].[细胞减灭术联合腹腔热灌注化疗治疗复发性炎性肌纤维母细胞肉瘤所致腹膜癌病:1例报告并文献复习]
Orv Hetil. 2006 Jan 29;147(4):147-58.
3
Treatment and prevention of peritoneal carcinomatosis from gastric cancer by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: overview and rationale.细胞减灭术和腹腔热灌注化疗治疗和预防胃癌腹膜转移癌:概述和原理。
Eur J Surg Oncol. 2013 Dec;39(12):1309-16. doi: 10.1016/j.ejso.2013.10.010. Epub 2013 Oct 23.
4
Feasibility of peritonectomy associated with intraperitoneal hyperthermic perfusion in patients with Pseudomyxoma peritonei.腹膜假黏液瘤患者行腹膜切除联合腹腔热灌注的可行性
Tumori. 2002 Sep-Oct;88(5):370-5. doi: 10.1177/030089160208800504.
5
Current role of hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis from colorectal cancer.腹腔内热化疗在结直肠癌腹膜转移治疗中的应用现状。
World J Gastroenterol. 2010 Mar 21;16(11):1299-302. doi: 10.3748/wjg.v16.i11.1299.
6
Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in peritoneal carcinomatosis.腹膜癌的减瘤手术及腹腔热灌注化疗
Isr Med Assoc J. 2007 Nov;9(11):787-90.
7
Prognostic factor analysis of circulating tumor cells in peripheral blood of patients with peritoneal carcinomatosis of colon cancer origin treated with cytoreductive surgery plus an intraoperative hyperthermic intraperitoneal chemotherapy procedure (CRS + HIPEC).接受细胞减灭术加术中腹腔内热化疗(CRS + HIPEC)治疗的结肠癌源性腹膜癌患者外周血循环肿瘤细胞的预后因素分析
Surgery. 2016 Mar;159(3):728-35. doi: 10.1016/j.surg.2015.09.013. Epub 2015 Oct 28.
8
[Peritoneal carcinomatosis of colorectal cancer: cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].[结直肠癌腹膜癌转移:细胞减灭术与腹腔热灌注化疗]
Dtsch Med Wochenschr. 2011 Sep;136(36):1811-4. doi: 10.1055/s-0031-1286108. Epub 2011 Aug 31.
9
Hyperthermic intraperitoneal chemotherapy after cytoreductive surgery for the treatment of peritoneal carcinomatosis in pediatric solid malignancies: a single institution experience.细胞减灭术后腹腔内热化疗治疗小儿实体恶性肿瘤腹膜转移癌:单中心经验
J Pediatr Surg. 2014 Aug;49(8):1276-9. doi: 10.1016/j.jpedsurg.2014.01.054. Epub 2014 Feb 10.
10
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: long-term results at St George Hospital, Australia.肿瘤细胞减灭术及腹腔热灌注化疗:澳大利亚圣乔治医院的长期结果
ANZ J Surg. 2016 Nov;86(11):937-941. doi: 10.1111/ans.13152. Epub 2015 Jul 14.

引用本文的文献

1
Predictive Value of C-Reactive Protein for Infectious Complications After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Single-Center Prospective Study.C 反应蛋白对细胞减灭术和腹腔热灌注化疗后感染并发症的预测价值:一项单中心前瞻性研究。
Ann Surg Oncol. 2024 Dec;31(13):8538-8548. doi: 10.1245/s10434-024-15986-3. Epub 2024 Aug 12.
2
Unveiling the Metabolic Maze: FDG PET/CT Findings in Peritoneal Carcinomatosis - A Case Series.揭开代谢迷宫:腹膜癌病的氟代脱氧葡萄糖正电子发射断层显像/计算机断层扫描结果——病例系列
Asia Ocean J Nucl Med Biol. 2024;12(2):189-201. doi: 10.22038/AOJNMB.2024.78270.1552.
3
Development of the Peritoneal Metastasis: A Review of Back-Grounds, Mechanisms, Treatments and Prospects.
腹膜转移的发展:背景、机制、治疗与前景综述
J Clin Med. 2022 Dec 23;12(1):103. doi: 10.3390/jcm12010103.
4
Current role for cytoreduction and HIPEC for gastric cancer with peritoneal disease.胃癌伴腹膜疾病行细胞减灭术和 HIPEC 的现状。
J Surg Oncol. 2022 Jun;125(7):1176-1182. doi: 10.1002/jso.26894.
5
Visual PET/CT scoring of mesenteric fdg uptake to differentiate between tuberculous peritonitis and peritoneal carcinomatosis.基于肠系膜 FDG 摄取的视觉 PET/CT 评分来鉴别结核性腹膜炎与腹腔癌转移。
Diagn Interv Radiol. 2020 Nov;26(6):523-530. doi: 10.5152/dir.2020.20088.
6
Rationale and techniques of cytoreductive surgery and peritoneal chemohyperthermia.细胞减灭术和腹腔温热化疗的原理和技术。
World J Gastrointest Oncol. 2011 Dec 15;3(12):169-74. doi: 10.4251/wjgo.v3.i12.169.
7
New approach to peritoneal surface malignancies.腹膜表面恶性肿瘤的新方法。
World J Gastrointest Oncol. 2010 Jan 15;2(1):9-11. doi: 10.4251/wjgo.v2.i1.9.
8
Management of pseudomyxoma peritonei.腹膜假黏液瘤的管理
World J Gastroenterol. 2006 Oct 14;12(38):6124-7. doi: 10.3748/wjg.v12.i38.6124.
9
Insufficient ability of omental milky spots to prevent peritoneal tumor outgrowth supports omentectomy in minimal residual disease.网膜乳斑阻止腹膜肿瘤生长的能力不足支持在微小残留病时行网膜切除术。
Cancer Immunol Immunother. 2006 Sep;55(9):1043-51. doi: 10.1007/s00262-005-0101-y. Epub 2005 Nov 26.